Stay updated on Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.

Latest updates to the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 is displayed. No substantive changes to study details or participation criteria are visible.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; no changes to the study details, eligibility criteria, or reported content are observed in the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the funding/operating-status notice from the page. The rest of the study details, locations, and eligibility information remain available on the page.SummaryDifference0.4%

- Check43 days agoChange DetectedNo additions or deletions were observed; the page content and layout appear unchanged. The study details page for NCT03305445 remains as before.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check79 days agoChange DetectedUpgraded to v3.1.0 by removing the topic 'Diffuse large B-cell lymphoma' from resources and keeping the version label as the primary change.SummaryDifference0.5%

Stay in the know with updates to Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.